Resources for Food and Drug Administration (FDA)

FDA cites toxic risk of popular head-lice drug

www.usatoday.com

The sole U.S. maker of an insecticide-based treatment for head lice has stopped promoting the product after a sharply worded warning from the Food and Drug Administration that its marketing misled consumers by downplaying the rare, but serious, risks of the treatments.

The move follows years of controversy over prescription shampoo and lotion treatments that contain the insecticide lindane, including a ban on their use in California. Lawmakers in Michigan, New York and Minnesota are considering curbing use of the products.

View the Resource

Share or bookmarklet this web page at: